Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 4
1949 1
1950 2
1951 1
1952 2
1954 3
1956 1
1959 2
1976 1
1977 1
1979 1
1980 1
1982 2
1983 1
1984 3
1985 1
1986 4
1987 2
1990 3
1991 7
1992 5
1993 7
1994 4
1995 1
1996 7
1997 7
1998 5
1999 5
2000 7
2001 4
2002 13
2003 19
2004 14
2005 8
2006 32
2007 30
2008 24
2009 24
2010 23
2011 29
2012 32
2013 36
2014 53
2015 53
2016 35
2017 38
2018 55
2019 55
2020 92
2021 74
2022 80
2023 79
2024 72
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

951 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Socio-Psychological Influences on Pain.
Drummond PD, Nicola M. Drummond PD, et al. Among authors: nicola m. Front Pain Res (Lausanne). 2023 Jan 9;3:1122466. doi: 10.3389/fpain.2022.1122466. eCollection 2022. Front Pain Res (Lausanne). 2023. PMID: 36700140 Free PMC article. No abstract available.
Eco-sustainability in ophthalmology.
Lee GG, Menean M, Williams BK Jr, Di Nicola M. Lee GG, et al. Among authors: di nicola m. Curr Opin Ophthalmol. 2024 Sep 1;35(5):403-408. doi: 10.1097/ICU.0000000000001070. Epub 2024 Jun 24. Curr Opin Ophthalmol. 2024. PMID: 38923880 Review.
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.
Martinotti G, Dell'Osso B, Di Lorenzo G, Maina G, Bertolino A, Clerici M, Barlati S, Rosso G, Di Nicola M, Marcatili M, d'Andrea G, Cavallotto C, Chiappini S, De Filippis S, Nicolò G, De Fazio P, Andriola I, Zanardi R, Nucifora D, Di Mauro S, Bassetti R, Pettorruso M, McIntyre RS, Sensi SL, di Giannantonio M, Vita A; REAL-ESK Study Group. Martinotti G, et al. Among authors: di nicola m. Bipolar Disord. 2023 May;25(3):233-244. doi: 10.1111/bdi.13296. Epub 2023 Jan 18. Bipolar Disord. 2023. PMID: 36636839 Free article.
Immunotherapy-based combinations: an update.
Fucà G, de Braud F, Di Nicola M. Fucà G, et al. Among authors: di nicola m. Curr Opin Oncol. 2018 Sep;30(5):345-351. doi: 10.1097/CCO.0000000000000466. Curr Opin Oncol. 2018. PMID: 29994900 Review.
Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden.
Schenker M, Burotto M, Richardet M, Ciuleanu TE, Gonçalves A, Steeghs N, Schoffski P, Ascierto PA, Maio M, Lugowska I, Lupinacci L, Leary A, Delord JP, Grasselli J, Tan DSP, Friedmann J, Vuky J, Tschaika M, Konduru S, Vemula SV, Slepetis R, Kollia G, Pacius M, Duong Q, Huang N, Doshi P, Baden J, Di Nicola M. Schenker M, et al. Among authors: di nicola m. J Immunother Cancer. 2024 Aug 6;12(8):e008872. doi: 10.1136/jitc-2024-008872. J Immunother Cancer. 2024. PMID: 39107131 Free PMC article. Clinical Trial.
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study.
Avallone G, Cavallo F, Tancredi A, Maronese CA, Bertello M, Fraghì A, Conforti C, Calabrese G, Di Nicola MR, Oddenino GA, Gargiulo L, Gori N, Loi C, Romita P, Piras V, Bonzano L, Tolino E, Paolino G, Napolitano M, Patruno C, Nettis E, Ferreli C, Roccuzzo G, Marozio L, Silvio M, Russo F, Bettolini L, Gallo R, Mercuri SR, Mastorino L, Rossi M, Zalaudek I, Argenziano G, Trave I, Costanzo A, Chiricozzi A, Gurioli C, Foti C, Potenza C, Ferrucci SM, Balato A, Parodi A, Marzano AV, Ortoncelli M, Ribero S, Quaglino P. Avallone G, et al. Among authors: di nicola mr. J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1799-1808. doi: 10.1111/jdv.19794. Epub 2024 Jan 29. J Eur Acad Dermatol Venereol. 2024. PMID: 38284131
Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade.
Rivoltini L, Camisaschi C, Fucà G, Paolini B, Vergani B, Beretta V, Damian S, Duca M, Cresta S, Magni M, Leone BE, Castelli C, de Braud F, De Santis F, Di Nicola M. Rivoltini L, et al. Among authors: di nicola m. Sci Rep. 2024 Feb 9;14(1):3379. doi: 10.1038/s41598-024-54041-9. Sci Rep. 2024. PMID: 38336861 Free PMC article. Clinical Trial.
Lymphoma Immunotherapy: Current Status.
Zappasodi R, de Braud F, Di Nicola M. Zappasodi R, et al. Among authors: di nicola m. Front Immunol. 2015 Sep 1;6:448. doi: 10.3389/fimmu.2015.00448. eCollection 2015. Front Immunol. 2015. PMID: 26388871 Free PMC article. Review.
951 results